Questcor Pharmacueticals (QCOR) Tops Q1 EPS by 10c; Revs Heavy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts QCOR Hot Sheet
Join SI Premium – FREE
Questcor Pharmacueticals (NASDAQ: QCOR) reported Q1 EPS of $0.61, $0.10 better than the analyst estimate of $0.51. Revenue for the quarter came in at $96 million versus the consensus estimate of $87.08 million.
For earnings history and earnings-related data on Questcor Pharmacueticals (QCOR) click here.
For earnings history and earnings-related data on Questcor Pharmacueticals (QCOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Dollar Tree shares drop amid analyst downgrade pressure
- Booz Allen Hamilton falls despite earnings beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
